The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
The University of Texas MD Anderson Cancer Center · Mirna Therapeutics (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,404
total citations
- FWCI
- 54.95
- Percentile
- 100%
- References
- 40
Citations per year
Authors
15- CLCan LiuCorresponding
The University of Texas MD Anderson Cancer Center
- KKKevin Kelnar
Mirna Therapeutics (United States)
- BLBigang Liu
The University of Texas MD Anderson Cancer Center
- XCXin Chen
The University of Texas MD Anderson Cancer Center
- TCTammy Calhoun‐Davis
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- CD44
- Prostate cancer
- Cancer stem cell
- Metastasis
- Cancer research
- Prostate
- Cancer
- Clonogenic assay
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.